Your browser doesn't support javascript.
loading
TAK1 binding protein 2 is essential for liver protection from stressors.
Ikeda, Yuka; Morioka, Sho; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun.
Afiliação
  • Ikeda Y; Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.
  • Morioka S; Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.
  • Matsumoto K; Department of Molecular Biology, Graduate School of Science, Nagoya University, Nagoya, Japan.
  • Ninomiya-Tsuji J; Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.
PLoS One ; 9(2): e88037, 2014.
Article em En | MEDLINE | ID: mdl-24498425
ABSTRACT
The liver is the first line of defense from environmental stressors in that hepatocytes respond to and metabolize them. Hence, hepatocytes can be damaged by stressors. Protection against hepatic cell damage and cell death is important for liver function and homeostasis. TAK1 (MAP3K7) is an intermediate of stressors such as bacterial moieties-induced signal transduction pathways in several cell types. Tak1 deficiency has been reported to induce spontaneous hepatocellular carcinoma. However, the regulatory mechanism of TAK1 activity in liver stress response has not yet been defined. Here we report that activation of TAK1 through TAK1 binding protein 2 (TAB2) is required for liver protection from stressors. We found that a bacterial moiety, lipopolysaccharides (LPS), activated TAK1 in primary hepatocytes, which was diminished by deletion of TAB2. Mice having hepatocyte-specific deletion of the Tab2 gene exhibited only late-onset moderate liver lesions but were hypersensitive to LPS-induced liver injury. Furthermore, we show that a chemical stressor induced greatly exaggerated liver injury in hepatocyte-specific Tab2-deficient mice. These results demonstrate that TAB2 is a sensor of stress conditions in the liver and functions to protect the liver by activating the TAK1 pathway.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Apoptose / MAP Quinase Quinase Quinases / Proteínas Adaptadoras de Transdução de Sinal / Dietilnitrosamina / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Apoptose / MAP Quinase Quinase Quinases / Proteínas Adaptadoras de Transdução de Sinal / Dietilnitrosamina / Doença Hepática Induzida por Substâncias e Drogas Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article